Skip to main content
Erschienen in: World Journal of Urology 6/2019

10.09.2018 | Original Article

Inferring bladder cancer research prioritization from patient-generated online content

verfasst von: Matthew Mossanen, Alice Chu, Angela B. Smith, John L. Gore

Erschienen in: World Journal of Urology | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Patients and their families utilize online resources when dealing with a diagnosis of bladder cancer. Many patients have questions regarding clinical management options. Online research forums may help researchers and providers identify research areas of interest. Our objective was to review online forums and identify research questions that are important to patients and families impacted by bladder cancer diagnosis.

Methods

We reviewed 1 month of online content from the Bladder Cancer Advocacy Network Inspire online community (https://​www.​inspire.​com/​groups/​bladder-cancer-advocacy-network). Using affinity diagramming, we categorized the submitted content from patient users into themes stratified by the cancer severity of the patient user (non-muscle-invasive bladder cancer, muscle-invasive bladder cancer, metastatic bladder cancer). We categorized the content by the audience of forum posts (i.e., inwardly directed, those seeking support, vs. outwardly directed, those sharing personal experiences) and constructed comparative effectiveness research questions from the submitted content.

Results

From 14 July 2014 to 14 August 2014, a total of 394 forum posts were collected, of which 3 were excluded from analysis due to non-relevant content, leaving 391 comments for final analysis. Almost 38% of posts involved muscle-invasive bladder cancer and 25% of posts were from people other than the patient. Inwardly and outwardly directed posts were commonly related to clinical treatment concerns.

Conclusions

Review of online patient-generated content may offer insight into comparative effectiveness research topics of importance to bladder cancer patients. A more formalized process may better represent research priorities among bladder cancer patients.
Literatur
1.
Zurück zum Zitat Mossanen M, Gore JL (2014) The burden of bladder cancer care: direct and indirect costs. Curr Opin Urol 24:487–491CrossRefPubMed Mossanen M, Gore JL (2014) The burden of bladder cancer care: direct and indirect costs. Curr Opin Urol 24:487–491CrossRefPubMed
3.
Zurück zum Zitat Epstein RM, Fiscella K, Lesser CS, Stange KC (2010) Why the nation needs a policy push on patient-centered health care. Health Aff 29:1489–1495CrossRef Epstein RM, Fiscella K, Lesser CS, Stange KC (2010) Why the nation needs a policy push on patient-centered health care. Health Aff 29:1489–1495CrossRef
4.
Zurück zum Zitat Hibbard JH, Greene J (2013) What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs. Health Aff 32:207–214CrossRef Hibbard JH, Greene J (2013) What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs. Health Aff 32:207–214CrossRef
5.
Zurück zum Zitat Mossanen M, Calvert JK, Wright JL, True LD, Lin DW, Gore JL (2014) Readability of urologic pathology reports: the need for patient-centered approaches. Urol Oncol 32:1091–1094CrossRefPubMed Mossanen M, Calvert JK, Wright JL, True LD, Lin DW, Gore JL (2014) Readability of urologic pathology reports: the need for patient-centered approaches. Urol Oncol 32:1091–1094CrossRefPubMed
6.
Zurück zum Zitat Mossanen M, True LD, Wright JL, Vakar-Lopez F, Lavallee D, Gore JL (2014) Surgical pathology and the patient: a systematic review evaluating the primary audience of pathology reports. Hum Pathol 45:2192–2201CrossRefPubMed Mossanen M, True LD, Wright JL, Vakar-Lopez F, Lavallee D, Gore JL (2014) Surgical pathology and the patient: a systematic review evaluating the primary audience of pathology reports. Hum Pathol 45:2192–2201CrossRefPubMed
7.
Zurück zum Zitat Mossanen M, Macleod LC, Chu A, Wright JL, Dalkin B, Lin DW et al (2016) Comparative effectiveness of a patient centered pathology report for bladder cancer care. J Urol 196:1383–1389CrossRefPubMed Mossanen M, Macleod LC, Chu A, Wright JL, Dalkin B, Lin DW et al (2016) Comparative effectiveness of a patient centered pathology report for bladder cancer care. J Urol 196:1383–1389CrossRefPubMed
8.
Zurück zum Zitat Jacobs BL, Montgomery JS, Zhang Y, Skolarus TA, Weizer AZ, Hollenbeck BK (2012) Disparities in bladder cancer. Urol Oncol 30:81–88CrossRefPubMed Jacobs BL, Montgomery JS, Zhang Y, Skolarus TA, Weizer AZ, Hollenbeck BK (2012) Disparities in bladder cancer. Urol Oncol 30:81–88CrossRefPubMed
9.
Zurück zum Zitat Yim WW, Yetisgen M, Harris WP, Kwan SW (2016) Natural Language Processing in oncology: a review. JAMA Oncol. 2:797–804CrossRefPubMed Yim WW, Yetisgen M, Harris WP, Kwan SW (2016) Natural Language Processing in oncology: a review. JAMA Oncol. 2:797–804CrossRefPubMed
10.
Zurück zum Zitat Smith AB, Chisolm S, Deal A, Spangler A, Quale DZ, Bangs R et al (2018) Patient-centered prioritization of bladder cancer research. Cancer 124(15):3136–3144CrossRefPubMed Smith AB, Chisolm S, Deal A, Spangler A, Quale DZ, Bangs R et al (2018) Patient-centered prioritization of bladder cancer research. Cancer 124(15):3136–3144CrossRefPubMed
Metadaten
Titel
Inferring bladder cancer research prioritization from patient-generated online content
verfasst von
Matthew Mossanen
Alice Chu
Angela B. Smith
John L. Gore
Publikationsdatum
10.09.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 6/2019
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-018-2479-0

Weitere Artikel der Ausgabe 6/2019

World Journal of Urology 6/2019 Zur Ausgabe

Neu im Fachgebiet Urologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Prostatakarzinom: EU initiiert neues Screeningkonzept

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Blasenkarzinom – Biomarker statt Zytologie?

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.